Related Experiment Video
Updated: Aug 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)
E R Elias1, M B Irons, A D Hurley
1Department of Pediatrics, Tufts-New England Medical Center, Boston, Massachusetts, USA.
Insights
Cholesterol supplementation shows clinical benefits for children with Smith-Lemli-Opitz syndrome (SLOS). Treatment improved growth, development, and behavior with no adverse effects observed.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Smith-Lemli-Opitz syndrome (SLOS) is a genetic disorder characterized by impaired cholesterol synthesis.
- Patients with SLOS often present with a range of developmental and physical challenges due to cholesterol deficiency.
Purpose of the Study:
- To evaluate the clinical effects of cholesterol supplementation in children diagnosed with SLOS.
- To determine the safety and efficacy of cholesterol therapy in this patient population.
Main Methods:
- A cohort of 6 children with SLOS, aged birth to 11 years, received cholesterol supplementation.
- Pretreatment cholesterol levels were measured, and clinical outcomes were assessed during therapy.
Main Results:
- All patients experienced clinical benefits, including improved growth and developmental progress.
- Positive effects included reduced problem behaviors, enhanced pubertal progression, better infection tolerance, and amelioration of gastrointestinal issues, photosensitivity, and skin rashes.
- No adverse reactions to cholesterol supplementation were reported.
Conclusions:
- Cholesterol supplementation appears to be a safe and beneficial therapeutic approach for children with SLOS.
- Early or late intervention with cholesterol may yield positive clinical outcomes in SLOS patients.
Abstract:
We describe the clinical effects of cholesterol supplementation in 6 children with the RSH-"Smith-Lemli-Opitz" syndrome (SLOS). The children ranged in age from birth to 11 years at the onset of therapy, with pretreatment cholesterol levels ranging from 8 to 62 mg/dl. Clinical benefits of therapy were seen in all patients, irrespective of age at onset of treatment, or severity of cholesterol defect. Effects of treatment included improved growth, more rapid developmental progress, and a lessening of problem behaviors. Pubertal progression in older patients, a better tolerance of infection, improvement of gastrointestinal symptoms, and a diminution in photosensitivity and skin rashes were also noted. There were no adverse reactions to treatment with cholesterol. This preliminary study suggests that cholesterol supplementation may be of benefit to patients with the SLOS.
Related Concept Videos
Pleiotropy
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cushing Syndrome II: Pathophysiology

